article thumbnail

8 cannabis investors share their outlook on the European market in H1 2022

TechCrunch

However, things are moving on the legal side of the market — it appears medical cannabis still carries most of the momentum, and it is only accelerating. How are these issues informing your advice to your cannabis-related portfolio companies? Has the popularity of CBD products made investors more comfortable about recreational use?